The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »
AcelRX Pharmaceuticals recently submitted a new drug application to the U.S. Food and Drug Administration for ARX-04. Read More »
CVS Health recently launched Transform Diabetes Care, a program dedicated to helping clients improve member health outcomes. Read More »
Marrk Merritt, president and CEO of the Pharmaceutical Care Management Association, writes, "The truth is PBMs reduce costs for payers and consumers by 30 percent or more and are part of the solution. It’s time for drug manufacturers to take responsibility for their own business mistakes instead of blaming others." Read More »
Endo International, PLC, a subsidiary of Par Pharmaceutical, recently released mycophenolate mofetil hydrochloride (HCI) in the U.S. following Food and Drug Administration approval of its Abbreviated New Drug Application. Read More »
The results of a new study conducted by AARP show that pharmaceutical prices for brand name products has increased drastically. Read More »
Legislators in Missouri will move in the next session to bring the state into line with most of the rest of the country by heightening the standard on expert witness testimony in civil trials. Read More »
The American Pharmacists Association recently released a video that commemorates its Pharmacy-based Immunization Certificate Training Program’s 20th anniversary. Read More »
According a new research study conducted by Visante, pharmacy benefit managers are saving consumers and payers $941 on average per person a year. Read More »
RxGenomix's training program in Pharmacogenomics has been approved by the American Pharmacists Association as a continuing pharmacy education credit. Read More »
The American Pharmacists Association recently hosted 650 pharmacists at its 2016 Joint Federal Pharmacy Seminar in Oxon Hill, Maryland. Read More »
Coupons offered by drug companies play a significant role in keeping prescription costs high, according to the co-author of a report that lays out solutions to fix problems with the system. Read More »
According to a new report released by the 2016 Generic Drug Savings and Access in the United States, generic prescription drugs generated 328 percent increase in annual savings since 2005. Read More »
Co-pay coupons and discounts offered to consumers ultimately will lead to higher costs across society as they increasingly drive up premiums, according to one leading expert on prescription drugs. Read More »
Medicaid could see $51.1 billion over the next decade if a “full range of pharmacy benefit management tools” is employed, according to a new report completed by The Menges Group and released by the Pharmaceutical Care Management Association (PCMA). Read More »
Pharmacy benefit managers (PBMs) are proven in helping the control rising prescription drug prices and should be part of the solutions adopted by policymakers, writes Pharmaceutical Care Management Association (PCMA) President Mark Merritt in an op-ed published yesterday in The Hill. Read More »
Hepatitis C medication costs in 2015 proved lower for the U.S. than Europe and Japan, particularly prices negotiated by pharmacy benefit managers in Medicare Part D, the Pharmaceutical Care Management Association recently reported. Read More »
Mark Merritt, president and CEO of the Pharmaceutical Care Management Association (PCMA), recently testified before the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Read More »
Issues statement on Congressional hearing "Reviewing the Rising Price of EpiPens." Read More »
Alerts Sign-up
